XML 102 R61.htm IDEA: XBRL DOCUMENT
v3.25.4

Segment and Enterprise Reporting (Tables) | 12 Months Ended
--- | ---
Jan. 03, 2026
Segment Reporting [Abstract] |
Schedule of Segment Reporting Information, by Segment | Selected information for the healthcare segment is presented below for each of the years ended January 3, 2026, December 28, 2024 and December 30, 2023:
(in millions) | Year Ended January 3, 2026 |  | Year Ended December 28, 2024 |  | Year Ended December 30, 2023
Revenues: |  |  |  |  |
Healthcare | $ | 1,524.1 |  |  | $ | 1,395.2 |  |  | $ | 1,275.5 |
Other(1) | 2.8 |  |  | — |  |  | — |
Total revenues | $ | 1,526.9 |  |  | $ | 1,395.2 |  |  | $ | 1,275.5 |
Cost of goods: |  |  |  |  |
Healthcare | $ | 573.8 |  |  | $ | 581.7 |  |  | $ | 498.3 |
Other(1) | 7.9 |  |  | 19.2 |  |  | 11.6 |
Total costs of good sold | $ | 581.7 |  |  | $ | 600.9 |  |  | $ | 509.9 |
Gross profit: |  |  |  |  |
Segment gross profit | $ | 950.3 |  |  | $ | 813.6 |  |  | $ | 777.1 |
Acquired asset amortization(1)(2) | (6.6) |  |  | (1.8) |  |  | (1.9) |
Business transition and related costs(1)(3) | 1.5 |  |  | (14.8) |  |  | (4.9) |
Acquisitions, integrations, divestitures, and related costs(1)(4) | — |  |  | (0.1) |  |  | — |
Other(1) | — |  |  | (2.6) |  |  | (4.7) |
Total gross profit | $ | 945.2 |  |  | $ | 794.3 |  |  | $ | 765.6 |
__________________ (1) Management excludes certain revenues and expenses from segment gross profit. Management considers these excluded amounts to be non-recurring or non-operational and as such, are excluded from segment gross profit as this enables management to better understand operational results. (2) Acquired asset amortization is a non-GAAP financial measure. These transactions represent amortization expense in connection with business or assets acquisitions associated with acquired intangible assets including, but not limited to customer relationships, intellectual property, trade names and non-competition agreements. (3) Business transition and related costs are a non-GAAP financial measure. These transactions represent gains, losses, and other related costs associated with business transition plans. These items may include but are not limited to severance, relocation, consulting, leasehold exit costs, asset impairment, and other related costs to rationalize our operational footprint and optimize business results. (4) Acquisitions, integrations, divestitures, and related costs are a non-GAAP financial measure. These transactions represent gains, losses, and other related costs associated with acquisitions, integrations, investments, divestitures, assets impairments, and in-process research and development. For each of the years ended January 3, 2026, December 28, 2024 and December 30, 2023, total depreciation and amortization expense for the healthcare segment was $38.8 million, $48.5 million and $38.1 million, respectively. The Company’s total assets by segment are as follows:
(in millions) | January 3, 2026 |  | December 28, 2024
Total assets by segment: |  |  |
Healthcare | $ | 1,697.8 |  |  | $ | 1,589.7 |
Asset held-for-sale | 1.1 |  |  | 1,036.0 |
Total assets by segment | $ | 1,698.9 |  |  | $ | 2,625.7 |
The Company’s consolidated long-lived assets (tangible non-current assets) by geographic area are as follows:
(in millions, except percentages) | Year Ended January 3, 2026 |  | Year Ended December 28, 2024 |  |
Total long-lived assets by geographic area: |  |  |  |  |  |  |  |  |  |  |
United States | $ | 307.7 |  |  | 86.5 | % |  | $ | 312.5 |  |  | 87.9 | % |  |  |  |
International | 48.2 |  |  | 13.5 |  |  | 43.2 |  |  | 12.1 |  |  |  |  |
Total long-lived assets by geographic area | $ | 355.9 |  |  | 100.0 | % |  | $ | 355.7 |  |  | 100.0 | % |  |  |  |
The following schedule presents an analysis of the Company’s revenues based upon the geographic area (ship to location):
(in millions, except percentages) | Year Ended January 3, 2026 |  | Year Ended December 28, 2024 |  | Year Ended December 30, 2023
Total revenue by geographic area: |  |  |  |  |  |  |  |  |  |  |
United States (U.S.) | $ | 956.6 |  |  | 62.7 | % |  | $ | 889.3 |  |  | 63.7 | % |  | $ | 796.9 |  |  | 62.5 | %
Europe, Middle East and Africa | 391.4 |  |  | 25.6 |  |  | 349.7 |  |  | 25.1 |  |  | 312.3 |  |  | 24.5 |
Asia and Australia | 119.6 |  |  | 7.8 |  |  | 105.2 |  |  | 7.5 |  |  | 117.6 |  |  | 9.2 |
North and South America (excluding U.S.) | 59.3 |  |  | 3.9 |  |  | 51.0 |  |  | 3.7 |  |  | 48.7 |  |  | 3.8 |
Total revenue by geographic area | $ | 1,526.9 |  |  | 100.0 | % |  | $ | 1,395.2 |  |  | 100.0 | % |  | $ | 1,275.5 |  |  | 100.0 | %

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration